title: Glycoxidation-modified macrophages and lipid peroxidation products are associated with the progression of human diabetic nephropathy.
abstract: The aim of this study is to investigate the role of glomerular macrophages activated by glycoxidation and lipid peroxidation products in the progression of glomerular lesions in diabetic nephropathy. Renal biopsy samples from 43 patients with diabetes (age, 54 +/- 14 years) and 10 control cases were immunohistochemically examined for the expression of carboxymethyllysine (CML), a representative glycoxidative product; oxidized phosphatidylcholine (Ox-PC), a representative lipid peroxidation product; leukocyte common antigen (LCA); CD68; and macrophage scavenger receptor (MSR) class A. The severity of the diffuse lesions in each glomerulus was histologically graded from 0 to IV. When grade II and III lesions had Kimmelstiel-Wilson (KW) nodules, they were placed in a new category called grade III with KW nodules. The number of cells positive for CML, Ox-PC, LCA, CD68, and MSR was compared in different grades. The number of macrophages per glomerulus increased with the glomerular lesion grade and was highest in grade III with KW nodules. Conversely, the number of lymphocytes did not parallel the grade of glomerular lesions. Almost 50% of macrophages contained CML, and more than 40% of those were observed in exudative lesions, tuft adhesions, and at the periphery of KW nodules. Ox-PC accumulated in 50% of CML-positive macrophages, which coexpress MSR. Macrophages positive for CML and Ox-PC increased with the grade. Glomerular macrophages may be activated by glycoxidative and lipid peroxidation products through MSR and may have a role in the development of human diabetic glomerulosclerosis.
authors.affiliation: Departments of Second Pathology and Internal Medicine, School of Medicine, Fukuoka University, Fukuoka, Japan. nouesugi@fukuoka-u.ac.jp
authors.forename: N
authors.initials: N
authors.lastname: Uesugi
authors.forename: N
authors.initials: N
authors.lastname: Sakata
authors.forename: S
authors.initials: S
authors.lastname: Horiuchi
authors.forename: R
authors.initials: R
authors.lastname: Nagai
authors.forename: M
authors.initials: M
authors.lastname: Takeya
authors.forename: J
authors.initials: J
authors.lastname: Meng
authors.forename: T
authors.initials: T
authors.lastname: Saito
authors.forename: S
authors.initials: S
authors.lastname: Takebayashi
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015703:Antigens, CD / Q000032:analysis; D015214:Antigens, Differentiation, Myelomonocytic / Q000032:analysis; D003928:Diabetic Nephropathies / Q000150:complications* / Q000473:pathology; D005260:Female; D006031:Glycosylation; D006801:Humans; D007150:Immunohistochemistry; D007678:Kidney Glomerulus / Q000378:metabolism / Q000473:pathology*; D017493:Leukocyte Common Antigens / Q000032:analysis; D015227:Lipid Peroxidation; D008239:Lysine / Q000031:analogs & derivatives* / Q000378:metabolism*; D008264:Macrophages / Q000737:chemistry / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D010713:Phosphatidylcholines / Q000378:metabolism*; D011971:Receptors, Immunologic / Q000032:analysis; D051116:Receptors, Scavenger; D051117:Scavenger Receptors, Class A; D012720:Severity of Illness Index; D000097382:CD68 Molecule
chemical_list: D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D017493:Leukocyte Common Antigens; D008239:Lysine; D010713:Phosphatidylcholines; D011971:Receptors, Immunologic; D051116:Receptors, Scavenger; D051117:Scavenger Receptors, Class A; C067980:CD68 antigen, human; D000097382:CD68 Molecule; C495139:MSR1 protein, human; C048496:N(6)-carboxymethyllysine